Page Number 18
Powered by eGoldFax 10/30/2023 14:30 eGo ldFax Page 19/28

Psychiatric Evaluation
Admit Date: 10/28/2023
Besa Observation Date/Time: 10/29/23 16:56
clindamycin Oral 300 mg capsule Cleocin
gabapentin Oral 300 mg capsule Newzontin
gabapentin Oral 400 mg capsule Neurontin 1,200 FO TID91317 Anxiety
gabapentin Oral 800 mg TAB 1 ea Neurontin ms

hydrOXYzine hydrochloride Oral 50 Atarax
mg TAB 1 ea

lamoTRIgine Oral 25 mg tablet LaMICctal 25 mg FO DAILY

Seizures

methocarbamol Oral 500 mg tablet Robaxin 500 mg Po TID91321 P muscle
spasm

mirtazapine Oral 15 mg tablet Remeron 15 mg FO HS Sleep
nicotine 21 mg/24 hr TERF Habitrol

omeprazole Oral 20 mg delayed PriLOsEC 20 ng PO DAILY GERD
release capsule

prazosin Oral 1 mg capsule Minipress 1 mg FO HS

nightmares

QUEtiapine Oral 100 mg tablet SEROquel

QUEtiapine Oral 300 mg tablet SEROquel 300 mg FO HS Mood
sertraline Oral 50 mg tablet Zoloft 50 mg PO DAILY Mood
traMADol 50 mg TAB Ultram 100 mg BO TID91321 P Pain
Admission Meds:

Description Brand Dose Route Frequency PRN
Indication

gabapentin Oral 400 mg capsule Neurontin 1,200 PO TID91317 Anxiety

mg
methocarbamol Oral 500 mg tablet Robaxin 500 mg FO TID91321 P muscle
spasm
mirtazapine Oral 15 mg tablet Remeron 15 mg PO HS Sleep
omeprazole Oral 20 mg delayed PriLOsEC 20 mg PO DAILY GERD
release capsule
prazosin Oral 1 mg capsule Minipress 1 mg PO HS
nightmares
QUEtiapine Oral 300 mg tablet SEROquel 300 mg PO HS Mood
sertraline Oral 50 mg tablet Zoloft 50 mg FO DAILY Mood
traMADol Oral 50 mg tablet Ultram 100 mg FO TID91321 P Pain

‘Treatment History —$

History of Inpatient Treatment Yes

Number of hospitalizations 16+

Most recent admission: date and location Swedish Covenant 2 weeks ago
Age of first hospitalization 20

Reason for admission suicidal ideation, detox

TRAUMA AND ABUSE

Row Type of abuse Age of abuse By whom Details DCFS/APS DCFS/APS

Involvement Report Filed

Printed On: 10/30/2023 @ 12:37 Page 3 of 11

------------------------------
